Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07158853 · ClinicalTrials.gov registry record · NA

Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

A NA study of Opioid Use Disorder and Buprenorphine, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT07158853 is a NA study of Opioid Use Disorder and Buprenorphine that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 160 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07158853, a NA study of Opioid Use Disorder and Buprenorphine, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals under buprenorphine maintenance treatment for OUD (bOUD).

Conditions Studied

Opioid Use Disorder Buprenorphine

Interventions

  • DEVICE Transcranial Direct Current Stimulation (tDCS)
  • DEVICE Sham Stimulation

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2026-02-04
Est. Completion 2026-08-01
Phase NA

Sponsor

University of Minnesota

966 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07158853

The ClinicalTrials.gov registry entry for NCT07158853 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Direct Current Stimulation (tDCS) is the first listed.

NCT07158853 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07158853 about?

NCT07158853 is a clinical study titled "Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder". The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals under buprenorphine maintenance treatment for OUD (bOUD).

What is the current status of trial NCT07158853?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2026-02-04. Estimated completion is 2026-08-01.

What conditions does trial NCT07158853 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Buprenorphine.

What interventions are being tested in trial NCT07158853?

The interventions under investigation include: Transcranial Direct Current Stimulation (tDCS) (DEVICE), Sham Stimulation (DEVICE).

Who is sponsoring clinical trial NCT07158853?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07158853 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Buprenorphine

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.